IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-4010

  1. 1,869 Posts.
    lightbulb Created with Sketch. 1472
    Looking at this article briefly, great sign for IHL-675A for ARDS, no doubt IHL team and Camargo already know about this and maybe could help with our team's Pre-IND meeting w/ the FDA.

    Same stuff was written about CBD being used to prevent the cytokine storm being proven in animal models i.e Tetra Pharma, looking at IL-6 in particular etc. This we already know, nothing new. IHL-675A vastly superior to CBD as well etc
    Isn't it funny that this Austrian Hospital is effectively using CBD alone to treat COVID patients with ARDS? HUMAN patients.


    As a refresher, here's IHL-675A compared to CBD alone from the last set of In Vivo results. Mmm... speaks for itself.
    Even if IHL-675A in human trials was TEN TIMES less effective it would still probably be better than CBD alone, and CBD alone is actively being used for treatment. I like those odds.


    https://hotcopper.com.au/data/attachments/2880/2880051-6e2472018b8b30bcfe29104de7cf2d05.jpg

    This Austrian hospital only started using CBD on patients on 31 January 2021 according to Heute.
    If Israel officially approves CBD therapy in their hospitals, I have the feeling that the FDA will be even more inclined to help us out.
    Would that make Israel the first country in the world to officially approve CBD for ARDS?

    Very interesting developments, but what would be nice to see would be if Austrian Govt as a whole took notice and approved CBD for ARDS then the EU taking notice after that and encouraging member states to do the same.
    If this happens, IHL could likely make contact with the EMA and get IHL-675A approved with ease, FDA and EMA recognize each other.

    This could get exciting REAL QUICK. I will be keeping an eye on this one... anyone following please post more content if any of these speculations come true in the near future.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.